跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
OLUX-E
Authorized
STANDARD
OLUX-E
MAYNE PHARMA INC
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
886e0339530f48a9
Company
MAYNE PHARMA INC
Type
Standard
Approval Details
Approval Id
886e0339530f48a9
Drug Approval Canada Name
OLUX-E
Product Name
OLUX-E
Status
Cancelled Post Market
Status Date
2020-01-09
Original Market Date
2013-02-04
Din
02344408
Drug Class
Human
Dosage Form
Aerosol, Foam
Route Of Administration
Topical
Schedule
Prescription
Ahfs
84:06.00
Atc Original
D07AD01 CLOBETASOL
Atc Name
d 07 ad 01
Aig Number
0110995001
Company Name
MAYNE PHARMA INC
Company Address
1240 Sugg Parkway, Greenville, North Carolina, United States, 27834
Company Detail Path
/organization/mayne-pharma-inc
Company Information
Pharmaceutical Company Name
MAYNE PHARMA INC
Country Name
Spain
Province Name
Madrid
City Name
madrid,madrid,country_es
Address
CALLE RAIMUNDO FERNANDEZ VILLAVERDE 63
Active Ingredients
CLOBETASOL PROPIONATE
0.05 % / W/W
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
886e0339530f48a9
Type
Standard
Back to Health Canada Approvals
OLUX-E - Health Canada Drug Approval Details